BioSpace News Archive

Biotech Bay

Blade Therapeutics to Participate in Upcoming Investor Conferences - Mar 07, 2022

Blade Therapeutics, Inc. announced that Wendye Robbins, M.D., president and CEO, will present at two investor conferences in March.

March 7, 2022
·
12 min read
Horizon Therapeutics plc Announces FDA Has Granted Priority Review of the Supplemental Biologics License Application (sBLA) for the Concomitant Use of KRYSTEXXA® (pegloticase injection) Plus Methotrexate for People Living With Uncontrolled Gout

Horizon Therapeutics plc Announces FDA Has Granted Priority Review of the Supplemental Biologics License Application (sBLA) for the Concomitant Use of KRYSTEXXA ® (pegloticase injection) Plus Methotrexate for People Living With Uncontrolled Gout.

March 7, 2022
·
8 min read
BioForest

Alpine Immune Sciences Reports FDA Partial Clinical Hold on NEON-2 Trial of Davoceticept (ALPN-202) in Combination with Pembrolizumab

Alpine Immune Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its NEON-2 trial evaluating davoceticept.

March 7, 2022
·
5 min read
Biotech Beach

Therapeutic Solutions International Announces ApoptoCyte Procedure for Enhancing Stem Cell Activity

Therapeutic Solutions International announced today data on what the Company believes to be a novel procedure to enhance anti-inflammatory and regenerative activity of all mesenchymal stem cells.

March 7, 2022
·
3 min read
Genetown

Moderna Announces Memorandum of Understanding with the Government of the Republic of Kenya to Establish its First mRNA Manufacturing Facility in Africa

Moderna, Inc. announced that with the assistance of the U.S. Government, it has entered into a Memorandum of Understanding with the Government of the Republic of Kenya to establish Kenya as the location for the Company’s mRNA manufacturing facility.

March 7, 2022
·
6 min read